News | May 07, 2026
CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
PMDA is regarded among the most stringent regulatory bodies globally
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
This certification paves the way for CORONA's entry into five EAEU member nations- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan-under a B2B business model
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
The audit was completed with zero critical and zero major observations
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Subscribe To Our Newsletter & Stay Updated
